Docetaxel (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Docetaxel" in Italian language version.

refsWebsite

Global rank Italian rank

17nih.gov

4^th place

9^th place

10oadoi.org

799^th place

22^nd place

10doi.org

2^nd place

7^th place

1web.archive.org

1^st place

1europa.eu

68^th place

57^th place

1molbiolcell.org

low place

1aacrjournals.org

8,869^th place

7,853^rd place

1archive.org

6^th place

8^th place

1rxlist.com

7,927^th place

low place

aacrjournals.org

clincancerres.aacrjournals.org

Baker SD, Zhao M, Lee CK, Verweij J, Zabelina Y, Brahmer JR, Wolff AC, Sparreboom A, Carducci MA, Comparative pharmacokinetics of weekly and every-three-weeks docetaxel, in Clin. Cancer Res., vol. 10, n. 6, 2004, pp. 1976–83, PMID 15041715. URL consultato il 17 gennaio 2015.

archive.org

Urien S, Barré J, Morin C, Paccaly A, Montay G, Tillement JP, Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein, in Invest New Drugs, vol. 14, n. 2, 1996, pp. 147–51, PMID 8913835.

doi.org

dx.doi.org

Clarke SJ, Rivory LP, Clinical pharmacokinetics of docetaxel, in Clin Pharmacokinet, vol. 36, n. 2, 1999, pp. 99–114, DOI:10.2165/00003088-199936020-00002, PMID 10092957.
Ten Tije AJ, Verweij J, Loos WJ, Sparreboom A, Pharmacological effects of formulation vehicles : implications for cancer chemotherapy, in Clin Pharmacokinet, vol. 42, n. 7, 2003, pp. 665–85, DOI:10.2165/00003088-200342070-00005, PMID 12844327.
Hennenfent KL, Govindan R, Novel formulations of taxanes: a review. Old wine in a new bottle?, in Ann. Oncol., vol. 17, n. 5, 2006, pp. 735–49, DOI:10.1093/annonc/mdj100, PMID 16364960.
Guitton J, Cohen S, Tranchand B, Vignal B, Droz JP, Guillaumont M, Manchon M, Freyer G, Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry, in Rapid Commun. Mass Spectrom., vol. 19, n. 17, 2005, pp. 2419–26, DOI:10.1002/rcm.2072, PMID 16059877.
Eniu A, Palmieri FM, Perez EA, Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer, in Oncologist, vol. 10, n. 9, 2005, pp. 665–85, DOI:10.1634/theoncologist.10-9-665, PMID 16249346.
Cardonick E, Bhat A, Gilmandyar D, Somer R, Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature, in Ann. Oncol., vol. 23, n. 12, 2012, pp. 3016–23, DOI:10.1093/annonc/mds170, PMID 22875836.
Rouzi AA, Sahly NN, Sahly NF, Alahwal MS, Cisplatinum and docetaxel for ovarian cancer in pregnancy, in Arch. Gynecol. Obstet., vol. 280, n. 5, 2009, pp. 823–5, DOI:10.1007/s00404-009-0992-5, PMID 19242705.
Potluri V, Lewis D, Burton GV, Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature, in Clin. Breast Cancer, vol. 7, n. 2, Giugno 2006, pp. 167–70, DOI:10.3816/CBC.2006.n.029, PMID 16800979.
Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F, Emerging therapeutic options for breast cancer chemotherapy during pregnancy, in Ann. Oncol., vol. 19, n. 4, 2008, pp. 607–13, DOI:10.1093/annonc/mdm460, PMID 17921242.
Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R, Taxanes for breast cancer during pregnancy: a systematic review, in Ann. Oncol., vol. 21, n. 2, Febbraio 2010, pp. 425–6, DOI:10.1093/annonc/mdp517, PMID 19887464.

europa.eu

ema.europa.eu

European Medicines Agency - Taxotere - Authorisation details, su ema.europa.eu. URL consultato il 16 gennaio 2015.

molbiolcell.org

Yvon AM, Wadsworth P, Jordan MA, Taxol suppresses dynamics of individual microtubules in living human tumor cells, in Mol. Biol. Cell, vol. 10, n. 4, 1999, pp. 947–59, PMC 25218, PMID 10198049. URL consultato il 18 gennaio 2015.

nih.gov

ncbi.nlm.nih.gov

Yvon AM, Wadsworth P, Jordan MA, Taxol suppresses dynamics of individual microtubules in living human tumor cells, in Mol. Biol. Cell, vol. 10, n. 4, 1999, pp. 947–59, PMC 25218, PMID 10198049. URL consultato il 18 gennaio 2015.
Lyseng-Williamson KA, Fenton C, Docetaxel: a review of its use in metastatic breast cancer, in Drugs, vol. 65, n. 17, 2005, pp. 2513–31, PMID 16296875.
Eisenhauer EA, Vermorken JB, The taxoids. Comparative clinical pharmacology and therapeutic potential, in Drugs, vol. 55, n. 1, 1998, pp. 5–30, PMID 9463787.
Baker SD, Zhao M, Lee CK, Verweij J, Zabelina Y, Brahmer JR, Wolff AC, Sparreboom A, Carducci MA, Comparative pharmacokinetics of weekly and every-three-weeks docetaxel, in Clin. Cancer Res., vol. 10, n. 6, 2004, pp. 1976–83, PMID 15041715. URL consultato il 17 gennaio 2015.
Clarke SJ, Rivory LP, Clinical pharmacokinetics of docetaxel, in Clin Pharmacokinet, vol. 36, n. 2, 1999, pp. 99–114, DOI:10.2165/00003088-199936020-00002, PMID 10092957.
Urien S, Barré J, Morin C, Paccaly A, Montay G, Tillement JP, Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein, in Invest New Drugs, vol. 14, n. 2, 1996, pp. 147–51, PMID 8913835.
Ten Tije AJ, Verweij J, Loos WJ, Sparreboom A, Pharmacological effects of formulation vehicles : implications for cancer chemotherapy, in Clin Pharmacokinet, vol. 42, n. 7, 2003, pp. 665–85, DOI:10.2165/00003088-200342070-00005, PMID 12844327.
Hennenfent KL, Govindan R, Novel formulations of taxanes: a review. Old wine in a new bottle?, in Ann. Oncol., vol. 17, n. 5, 2006, pp. 735–49, DOI:10.1093/annonc/mdj100, PMID 16364960.
Guitton J, Cohen S, Tranchand B, Vignal B, Droz JP, Guillaumont M, Manchon M, Freyer G, Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry, in Rapid Commun. Mass Spectrom., vol. 19, n. 17, 2005, pp. 2419–26, DOI:10.1002/rcm.2072, PMID 16059877.
Eniu A, Palmieri FM, Perez EA, Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer, in Oncologist, vol. 10, n. 9, 2005, pp. 665–85, DOI:10.1634/theoncologist.10-9-665, PMID 16249346.
Burris HA, Optimal use of docetaxel (Taxotere): maximizing its potential, in Anticancer Drugs, 7 Suppl 2, 1996, pp. 25–28, PMID 8862707.
Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V, Cancer chemotherapy and pregnancy, in J Obstet Gynaecol Can, vol. 35, n. 3, Marzo 2013, pp. 263–80, PMID 23470115.
Cardonick E, Bhat A, Gilmandyar D, Somer R, Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature, in Ann. Oncol., vol. 23, n. 12, 2012, pp. 3016–23, DOI:10.1093/annonc/mds170, PMID 22875836.
Rouzi AA, Sahly NN, Sahly NF, Alahwal MS, Cisplatinum and docetaxel for ovarian cancer in pregnancy, in Arch. Gynecol. Obstet., vol. 280, n. 5, 2009, pp. 823–5, DOI:10.1007/s00404-009-0992-5, PMID 19242705.
Potluri V, Lewis D, Burton GV, Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature, in Clin. Breast Cancer, vol. 7, n. 2, Giugno 2006, pp. 167–70, DOI:10.3816/CBC.2006.n.029, PMID 16800979.
Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F, Emerging therapeutic options for breast cancer chemotherapy during pregnancy, in Ann. Oncol., vol. 19, n. 4, 2008, pp. 607–13, DOI:10.1093/annonc/mdm460, PMID 17921242.
Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R, Taxanes for breast cancer during pregnancy: a systematic review, in Ann. Oncol., vol. 21, n. 2, Febbraio 2010, pp. 425–6, DOI:10.1093/annonc/mdp517, PMID 19887464.

oadoi.org

Clarke SJ, Rivory LP, Clinical pharmacokinetics of docetaxel, in Clin Pharmacokinet, vol. 36, n. 2, 1999, pp. 99–114, DOI:10.2165/00003088-199936020-00002, PMID 10092957.
Ten Tije AJ, Verweij J, Loos WJ, Sparreboom A, Pharmacological effects of formulation vehicles : implications for cancer chemotherapy, in Clin Pharmacokinet, vol. 42, n. 7, 2003, pp. 665–85, DOI:10.2165/00003088-200342070-00005, PMID 12844327.
Hennenfent KL, Govindan R, Novel formulations of taxanes: a review. Old wine in a new bottle?, in Ann. Oncol., vol. 17, n. 5, 2006, pp. 735–49, DOI:10.1093/annonc/mdj100, PMID 16364960.
Guitton J, Cohen S, Tranchand B, Vignal B, Droz JP, Guillaumont M, Manchon M, Freyer G, Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry, in Rapid Commun. Mass Spectrom., vol. 19, n. 17, 2005, pp. 2419–26, DOI:10.1002/rcm.2072, PMID 16059877.
Eniu A, Palmieri FM, Perez EA, Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer, in Oncologist, vol. 10, n. 9, 2005, pp. 665–85, DOI:10.1634/theoncologist.10-9-665, PMID 16249346.
Cardonick E, Bhat A, Gilmandyar D, Somer R, Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature, in Ann. Oncol., vol. 23, n. 12, 2012, pp. 3016–23, DOI:10.1093/annonc/mds170, PMID 22875836.
Rouzi AA, Sahly NN, Sahly NF, Alahwal MS, Cisplatinum and docetaxel for ovarian cancer in pregnancy, in Arch. Gynecol. Obstet., vol. 280, n. 5, 2009, pp. 823–5, DOI:10.1007/s00404-009-0992-5, PMID 19242705.
Potluri V, Lewis D, Burton GV, Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature, in Clin. Breast Cancer, vol. 7, n. 2, Giugno 2006, pp. 167–70, DOI:10.3816/CBC.2006.n.029, PMID 16800979.
Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F, Emerging therapeutic options for breast cancer chemotherapy during pregnancy, in Ann. Oncol., vol. 19, n. 4, 2008, pp. 607–13, DOI:10.1093/annonc/mdm460, PMID 17921242.
Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R, Taxanes for breast cancer during pregnancy: a systematic review, in Ann. Oncol., vol. 21, n. 2, Febbraio 2010, pp. 425–6, DOI:10.1093/annonc/mdp517, PMID 19887464.

rxlist.com

Anonimo, Docefrez (docetaxel) Drug Information: Side Effects and Drug Interactions - Prescribing Information at RxList, su rxlist.com. URL consultato il 18 gennaio 2015.

web.archive.org

Anonymous. Oncology Tools: Approved Claims for microtubule inhibitors. US Food and Drug Administration. at web.archive.org (17 Sep 2006). Last modified 22 Jun 1998.